Identifying treatments that may be beneficial for people hospitalised with suspected or confirmed COVID-19.

Video recording of Usher Institute Annual Lecture 2021 with Professor Sir Martin Landray speaking on the RECOVERY trial.

The Recovery trial recruited people admitted to hospital with suspected or confirmed COVID-19, including pregnant women. This trial previously showed that low doses of dexamethasone (a type of steroid) reduced the risk of dying for some patients hospitalised with COVID-19. 

There were several other treatments thought to potentially be helpful (or possibly harmful) when added to the usual standard of care. This study aimed to find out whether any of these additional treatments were of any help. Only treatments which had been used before in pregnant women with pre-existing medical disorders where benefits outweigh the risks to fetus or woman (including in the first trimester), were used in the Recovery trial.

For further information, please visit the Recovery Study website:

Recovery Study Site